← Back to Search

Exposure Therapy for Anxiety Disorders (ETC Trial)

N/A
Recruiting
Led By Jasper Smits, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18-70
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

ETC Trial Summary

This trial is testing whether a single-session exposure to either a standard or enhanced treatment can reduce anxiety sensitivity relative to a control condition. The study will also test for possible moderators and mechanisms of action.

Who is the study for?
This trial is for students aged 18-70 enrolled in an introductory psychology course with high anxiety sensitivity (score ≥ 23 on ASI-3). It's not suitable for those with neurological disorders, current pregnancy, respiratory or cardiovascular conditions like asthma or high blood pressure, or medical issues that could affect exposure therapy participation.Check my eligibility
What is being tested?
The study compares a single-session large-group standard exposure therapy to enhanced exposure and a control condition. The goal is to see which method better reduces anxiety sensitivity. Participants will be randomly assigned to one of the three groups.See study design
What are the potential side effects?
While specific side effects are not detailed, exposure therapies may cause temporary increases in anxiety levels during treatment due to confrontation with feared stimuli but are generally considered safe.

ETC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 70 years old.

ETC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety Sensitivity
Secondary outcome measures
Anxiety
Change in Anxiety Sensitivity
Depression

ETC Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced ExposureExperimental Treatment1 Intervention
Psychoeducation about exposure therapy and anxiety sensitivity, interoceptive exposure therapy modeling and practice, and post-exposure processing aimed at emphasizing harm expectancy violation
Group II: ControlActive Control1 Intervention
General stress reduction based on stress management training to help people cope with feelings of anxiety, used as an active control condition
Group III: Standard ExposureActive Control1 Intervention
Psychoeducation about exposure therapy and anxiety sensitivity, interoceptive exposure therapy modeling and practice, and completion of questions about the exercises and the large-group aspect

Find a Location

Who is running the clinical trial?

University of GöttingenOTHER
66 Previous Clinical Trials
38,613 Total Patients Enrolled
University of North Carolina, Chapel HillOTHER
1,519 Previous Clinical Trials
4,195,280 Total Patients Enrolled
University of MiamiOTHER
911 Previous Clinical Trials
410,593 Total Patients Enrolled

Media Library

Enhanced Exposure Clinical Trial Eligibility Overview. Trial Name: NCT05225740 — N/A
Anxiety Sensitivity Research Study Groups: Control, Enhanced Exposure, Standard Exposure
Anxiety Sensitivity Clinical Trial 2023: Enhanced Exposure Highlights & Side Effects. Trial Name: NCT05225740 — N/A
Enhanced Exposure 2023 Treatment Timeline for Medical Study. Trial Name: NCT05225740 — N/A
~78 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top